Study of Stapled Transanal Rectal Resection (STARR) Surgery in Refractory Constipation Associated With Obstructive Defecation Syndrome (ODS)
NCT ID: NCT00256984
Last Updated: 2018-07-16
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
75 participants
INTERVENTIONAL
2005-10-01
2008-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Stapled TransAnal Rectal Resection (STARR) With Contour® TranstarTM
NCT00673400
International Multicenter Prospective Transtar Registry
NCT00909116
Does the Stapled Transanal Rectal Resection (STARR Procedure) Has an Effect on Anal Compliance ?
NCT02052063
Long Term Results of STARR With Contour Transtar
NCT02971332
Dynamic MRI Evaluation Post Operative Stapled Trans Anal Rectal Resection (STARR) Procedure
NCT00655382
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
For individuals with ODS and related intussusception/rectocele, a variety of surgical techniques including abdominal, vaginal, transanal and perineal approaches have been devised. The impact of clinical studies to evaluate these techniques has been limited by variability of results and lack of comparators. Recently, a new surgical approach was developed by an Italian surgeon, A. Longo, and has been evaluated in several European centers. These early studies and observations indicate that this new procedure may in fact provide significantly better symptom resolution in ODS patients than other available treatments, and warrants further study. The procedure is referred to as "Stapled Transanal Rectal Resection (STARR)" and this study will assess its effectiveness in a United States population.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Stapled Transanal Resection (STARR) with Transtar (PROXIMATE®) 33 mm Circular Stapler
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to comprehend, follow, and sign an informed consent document (ICD)
* Able to tolerate general or spinal anesthetic
* Often experience excessive straining, sense of incomplete evacuation, and/or prolonged time for complete evacuation when attempting a bowel movement
* Have experienced ODS symptoms for at least 12 months prior to enrollment
* Have a minimum ODS score of 10
* Have rectocele and/or rectal intussusception confirmed by defecography
* Screened for colorectal neoplasia within 7 years of the screening visit (e.g., colonoscopy or barium enema)
* Have an American Society of Anesthesiologists (ASA) score of no more than 3
* Willing to comply with evaluation and management schedule through 5-year follow-up
Exclusion Criteria
* Full-thickness prolapse
* Perineal infection
* Recto-vaginal fistula
* Enterocele (at rest)
* Any complex pelvic floor prolapse requiring a combined surgical approach
* Prior sigmoid or anterior resection or prior rectal anastomosis
* Presence of foreign material adjacent to the rectum (e.g., vaginal mesh)
* Grade IV hemorrhoids
* Pregnancy
* Chronic narcotic use
* Evidence of colorectal neoplasia, carcinoma, or inflammatory bowel disease
* Physical or psychological condition which would impair study participation
* Unable or unwilling to attend follow-up visits and examinations
* Surgical procedure required concurrently with STARR
* Prior pelvic radiotherapy
* Failure to identify any anatomical or physiological abnormality in the evaluation
* Significant rectal fibrosis
* Anal stenosis precluding insertion of the stapling device
* Participation in any other investigational device or drug study 30 days prior to enrollment
* Presence or history of hepatitis B, hepatitis C, and/or HIV positive test
21 Years
80 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ethicon Endo-Surgery
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robin F Scamuffa, MS
Role: STUDY_DIRECTOR
Ethicon Endo-Surgery
William Bernie, MD
Role: STUDY_DIRECTOR
Ethicon Endo-Surgery
Anthony J Senagore, MD
Role: PRINCIPAL_INVESTIGATOR
Medical University of Ohio
Anders F Mellgren, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Minnesota
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Colon and Rectal Clinic of Orlando
Orlando, Florida, United States
Lahey Clinic
Burlington, Massachusetts, United States
Colon & Rectal Surgery Associates Ltd.
Minneapolis, Minnesota, United States
University Hospitals of Cleveland
Cleveland, Ohio, United States
The Cleveland Clinic Foundation
Cleveland, Ohio, United States
Medical University of Ohio, Department of Surgery
Toledo, Ohio, United States
Portland Medical Center
Portland, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Shorvon PJ, McHugh S, Diamant NE, Somers S, Stevenson GW. Defecography in normal volunteers: results and implications. Gut. 1989 Dec;30(12):1737-49. doi: 10.1136/gut.30.12.1737.
Kenton K, Shott S, Brubaker L. The anatomic and functional variability of rectoceles in women. Int Urogynecol J Pelvic Floor Dysfunct. 1999;10(2):96-9. doi: 10.1007/pl00004019.
Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ 3rd. Functional constipation and outlet delay: a population-based study. Gastroenterology. 1993 Sep;105(3):781-90. doi: 10.1016/0016-5085(93)90896-k.
Siproudhis L, Dautreme S, Ropert A, Briand H, Renet C, Beusnel C, Juguet F, Rabot AF, Bretagne JF, Gosselin M. Anismus and biofeedback: who benefits? Eur J Gastroenterol Hepatol. 1995 Jun;7(6):547-52.
van Dam JH, Hop WC, Schouten WR. Analysis of patients with poor outcome of rectocele repair. Dis Colon Rectum. 2000 Nov;43(11):1556-60. doi: 10.1007/BF02236738.
Fleshman JW, Fry RD, Kodner IJ. The surgical management of constipation. Baillieres Clin Gastroenterol. 1992 Mar;6(1):145-62. doi: 10.1016/0950-3528(92)90024-9.
Altomare DF, Rinaldi M, Veglia A, Petrolino M, De Fazio M, Sallustio P. Combined perineal and endorectal repair of rectocele by circular stapler: a novel surgical technique. Dis Colon Rectum. 2002 Nov;45(11):1549-52. doi: 10.1007/s10350-004-6465-9.
Dodi G, Pietroletti R, Milito G, Binda G, Pescatori M. Bleeding, incontinence, pain and constipation after STARR transanal double stapling rectotomy for obstructed defecation. Tech Coloproctol. 2003 Oct;7(3):148-53. doi: 10.1007/s10151-003-0026-4.
Boccasanta P, Venturi M, Stuto A, Bottini C, Caviglia A, Carriero A, Mascagni D, Mauri R, Sofo L, Landolfi V. Stapled transanal rectal resection for outlet obstruction: a prospective, multicenter trial. Dis Colon Rectum. 2004 Aug;47(8):1285-96; discussion 1296-7. doi: 10.1007/s10350-004-0582-3.
Boccasanta P, Venturi M, Salamina G, Cesana BM, Bernasconi F, Roviaro G. New trends in the surgical treatment of outlet obstruction: clinical and functional results of two novel transanal stapled techniques from a randomised controlled trial. Int J Colorectal Dis. 2004 Jul;19(4):359-69. doi: 10.1007/s00384-003-0572-2. Epub 2004 Mar 13.
Pescatori M, Dodi G, Salafia C, Zbar AP. Rectovaginal fistula after double-stapled transanal rectotomy (STARR) for obstructed defaecation. Int J Colorectal Dis. 2005 Jan;20(1):83-5. doi: 10.1007/s00384-004-0658-5. Epub 2004 Sep 2. No abstract available.
Grassi R, Romano S, Micera O, Fioroni C, Boller B. Radiographic findings of post-operative double stapled trans anal rectal resection (STARR) in patient with obstructed defecation syndrome (ODS). Eur J Radiol. 2005 Mar;53(3):410-6. doi: 10.1016/j.ejrad.2004.12.012.
Mongardini M, Custureri F, Schillaci F, Cola A, Maturo A, Fanello G, Corelli S, Pappalardo G. [Prevention of post-operative pain and haemorrhage in PPH (Procedure for Prolapse and Hemorrhoids) and STARR (Stapled Trans-Anal Rectal Resection). Preliminary results in 261 cases]. G Chir. 2005 Apr;26(4):157-61. Italian.
Binda GA, Pescatori M, Romano G. The dark side of double-stapled transanal rectal resection. Dis Colon Rectum. 2005 Sep;48(9):1830-1; author reply 1831-2. doi: 10.1007/s10350-005-0103-z. No abstract available.
Jayne DG, Finan PJ. Stapled transanal rectal resection for obstructed defaecation and evidence-based practice. Br J Surg. 2005 Jul;92(7):793-4. doi: 10.1002/bjs.5092. No abstract available.
Talley NJ, Phillips SF, Wiltgen CM, Zinsmeister AR, Melton LJ 3rd. Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc. 1990 Nov;65(11):1456-79. doi: 10.1016/s0025-6196(12)62169-7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CI-05-0004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.